Overview
Nasopalpebral lipoma-coloboma syndrome (also known as Penchaszadeh syndrome) is an extremely rare congenital disorder characterized by the combination of congenital upper eyelid colobomas (notch-like defects in the eyelids) and symmetrical lipomas (benign fatty growths) affecting the nose and eyelids. The condition is present at birth and primarily affects structures of the face, particularly the eyes and nose. Key clinical features include bilateral upper eyelid colobomas, nasopalpebral lipomas that may extend from the inner corners of the eyes across the bridge of the nose, telecanthus (widely spaced inner corners of the eyes), and a broad nasal bridge. Some patients may also have additional findings such as sparse or absent eyebrows medially, and mild facial dysmorphism. Vision may be affected depending on the severity of the eyelid colobomas, which can lead to corneal exposure and associated complications if left untreated. The syndrome was first described by Penchaszadeh in 1982. It appears to follow an autosomal dominant inheritance pattern, though the underlying genetic cause has not been fully elucidated. The condition has been reported in a very small number of families worldwide. Treatment is primarily surgical and supportive, focusing on repair of the eyelid colobomas to protect the cornea and preserve vision, as well as cosmetic removal of the lipomas if desired. Early ophthalmologic evaluation is important to prevent corneal damage. With appropriate surgical management, the prognosis is generally favorable, as the condition does not typically involve systemic or life-threatening complications.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Nasopalpebral lipoma-coloboma syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Nasopalpebral lipoma-coloboma syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Nasopalpebral lipoma-coloboma syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Nasopalpebral lipoma-coloboma syndrome.
Community
No community posts yet. Be the first to share your experience with Nasopalpebral lipoma-coloboma syndrome.
Start the conversation →Latest news about Nasopalpebral lipoma-coloboma syndrome
No recent news articles for Nasopalpebral lipoma-coloboma syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Nasopalpebral lipoma-coloboma syndrome
What is Nasopalpebral lipoma-coloboma syndrome?
Nasopalpebral lipoma-coloboma syndrome (also known as Penchaszadeh syndrome) is an extremely rare congenital disorder characterized by the combination of congenital upper eyelid colobomas (notch-like defects in the eyelids) and symmetrical lipomas (benign fatty growths) affecting the nose and eyelids. The condition is present at birth and primarily affects structures of the face, particularly the eyes and nose. Key clinical features include bilateral upper eyelid colobomas, nasopalpebral lipomas that may extend from the inner corners of the eyes across the bridge of the nose, telecanthus (wide
How is Nasopalpebral lipoma-coloboma syndrome inherited?
Nasopalpebral lipoma-coloboma syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Nasopalpebral lipoma-coloboma syndrome typically begin?
Typical onset of Nasopalpebral lipoma-coloboma syndrome is neonatal. Age of onset can vary across affected individuals.